January 5, 2026 - The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted radiation therapy to minimize side effects while preserving efficacy in men with advanced prostate cancer.
“Our goal in this trial is to strategically improve both survival and quality
December 15, 2025
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Based on data from an Alliance for Clinical Trials in Oncology study, this finding could lead to more personalized treatments and better outcomes for patients.
Colon cancer is one of the most co
December 16, 2025
As we enter this holiday season, I would like to express my deep appreciation for your unwavering commitment to our shared mission of transforming cancer care through innovative, collaborative, patient-centered research. During the past year, you have shown your ability to adapt and thrive with resilience and clarity as we continue to navigate what seems to be a constantly changing landscape.
The momentum of our recent NCI-NCTN gra
